A Study of C-CAR066 in Subjects With r/r B Cell Lymphoma Who Received CD19 CAR-T Therapy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04036019|
Recruitment Status : Unknown
Verified July 2019 by Aibin Liang，MD，Ph.D., Shanghai Tongji Hospital, Tongji University School of Medicine.
Recruitment status was: Recruiting
First Posted : July 29, 2019
Last Update Posted : July 29, 2019
Shanghai Tongji Hospital, Tongji University School of Medicine
Cellular Biomedicine Group Ltd.
Information provided by (Responsible Party):
Aibin Liang，MD，Ph.D., Shanghai Tongji Hospital, Tongji University School of Medicine
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||May 1, 2021|
|Estimated Study Completion Date :||July 30, 2021|